Response to interferon α treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

Gut

Volumn 45, Issue 1, 1999, Pages 122-128

  Cresta, P ^a   Musset, L ^b   Cacoub, P ^d   Frangeul, L ^d   Vitour, D ^a   Poynard, T ^d   Opolon, P ^d   Nguyen, D T ^d   Golliot, F ^d   Piette, J C ^d   Huraux, J M ^d   Lunel, F ^a,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Service de Virologie   (France)

^d NONE

Author keywords

Chronic hepatitis C; Cryoglobulinaemia; Cryoglobulins; Hepatitis C virus; Interferon

Indexed keywords

ALPHA INTERFERON; CRYOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0032965502     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.1.122     Document Type: Article

References (33)

1. 1 Meltzer M, Elias K, McCluskey RT, et al. Cryoglobulinemia: a clinical and laboratory study. Am J Med 1966;40:837-56.
2. 2 Gorevic P, Kassab H, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
3. 3 Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. Am J Med 1974;57:775-88.
4. 4 Levo Y, Gorevic PD, Hanna MD, et al. Liver involvement in the syndrome of mixed cryoglobulinemia. Ann Intern Med 1977;87:287-92.
5. 5 Pascual M, Perrin L, Giostra E, et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990;162:569-70.
6. 6 Zarski JP, Rougier D, Aubert H, et al. Association cryoglobuline et maladie hépatique: fréquence, nature et caractères immuno-chimiques de la cryoglobulinémie. Gastroenterol Clin Biol 1984;8:845-50.
7. 7 Ferri C, Greco F, Longombardo G, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-10.
8. 8 Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-15.
9. 9 Cacoub P, Lunel F, Musset L, et al. Hepatitis C virus and cryoglobulinemia. N Engl J Med 1993;328;1121-2.
10. 10 Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994,106:1291-300.
11. 11 Agnello V. Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. Hepatology 1997;26:1375-9.
12. 12 Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic Non-A, Non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986; 315:1575-8.
13. 13 Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.
14. 14 Davis GL, Balart LA, Schiff ER, et al Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 1989;321: 1501-6.
15. 15 Marcellin P, Boyer N, Giostra E, et al. Recombinant human alpha-interferon in patients with chronic Non-A Non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991;13:393-7.
16. 16 Bonomo L, Casato M, Afeltra A, et al. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987;83:726-30.
17. 17 Casato M, Lagana B, Antonelli G, et al. Long-term results of therapy with Interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991;78:3142-7.
18. 18 Casato M, Agnello V, Pucillo LP, et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis virus C infection. Blood 1997;90:3865-73.
19. 19 Ferri C, Marzo M, Longombardo G, et al. Interferon alfa in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993;81:1132-6.
20. 20 Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
21. 21 Dammacco F, Sansonno D, Han JH, et al. Natural interferon alfa versus its combination with 6-methylprednisolone on the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994;84:3336-43.
22. 22 Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
23. 23 Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662-6.
24. 24 Musset L, Diemert MC, Taibi F, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
25. 25 Urdea MS, Horn T, Fulz TJ, et al. Branched DNA amplification multimers for the sensitive direct detection of human hepatitis viruses. Nucleic Acids Research Symposia and Seminars 1991:24:197-200.
26. 26 Stuyver L, Rossau R, Wyseru A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-102.
27. 27 Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
28. 28 Frangeul L, Musset L, Cresta P, et al. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996;25:427-32.
29. 29 Martinot-Peignoux M, Marcellin P, Pouteau M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995;22:1050-6.
30. 30 Chemello L, Cavalletto L, Noventa F, et al. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon alfa. J Viral Hepatitis 1995;2:91-6.
31. 31 Lunel F, Cresta P, Vitour D, et al. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Hepatology 1999;29:528-35.
32. 32 Van Thiel DH, Fagiuoli S, Caraceni P, et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995;22:464-7.
33. 33 Causse X, Godinot H, Chevallier M, et al. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1991;101: 497-502.